Diary - News All news Adocia Initiates Phase 2 Clinical Trial

Adocia Initiates Phase 2 Clinical Trial

Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes

Phase 2 study evaluates safety and efficacy of M1Pram, assessing weight loss in overweight and obese T1D patients as well as improved HbA1c
The study has been designed to define parameters for the upcoming Phase 3 trial planned for 2022
This study follows the promising results of the proof-of-concept Phase 1 trial announced on September 15, 2020